State Street’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,845,839
| Closed | -$113M | – | 4432 |
|
|
2024
Q1 | $113M | Buy |
2,845,839
+1,455,810
| +105% | +$57.7M | 0.01% | 1227 |
|
|
2023
Q4 | $26.5M | Buy |
1,390,029
+784,484
| +130% | +$15M | ﹤0.01% | 2053 |
|
|
2023
Q3 | $6.93M | Buy |
605,545
+32,703
| +6% | +$374K | ﹤0.01% | 2765 |
|
|
2023
Q2 | $5.89M | Buy |
572,842
+226,171
| +65% | +$2.33M | ﹤0.01% | 2919 |
|
|
2023
Q1 | $2.68M | Buy |
346,671
+43,253
| +14% | +$334K | ﹤0.01% | 3236 |
|
|
2022
Q4 | $2.23M | Buy |
303,418
+24,436
| +9% | +$180K | ﹤0.01% | 3346 |
|
|
2022
Q3 | $2.01M | Buy |
278,982
+10,900
| +4% | +$78.5K | ﹤0.01% | 3416 |
|
|
2022
Q2 | $2.28M | Buy |
268,082
+47,461
| +22% | +$404K | ﹤0.01% | 3432 |
|
|
2022
Q1 | $1.98M | Buy |
220,621
+14,609
| +7% | +$131K | ﹤0.01% | 3567 |
|
|
2021
Q4 | $2.85M | Buy |
206,012
+8,216
| +4% | +$114K | ﹤0.01% | 3513 |
|
|
2021
Q3 | $2.11M | Buy |
197,796
+24,677
| +14% | +$263K | ﹤0.01% | 3597 |
|
|
2021
Q2 | $1.56M | Buy |
+173,119
| New | +$1.56M | ﹤0.01% | 3588 |
|
|
2018
Q4 | – | Sell |
-10,126
| Closed | -$64K | – | 3793 |
|
|
2018
Q3 | $64K | Buy |
+10,126
| New | +$64K | ﹤0.01% | 3684 |
|
|
2016
Q2 | – | Sell |
-11,124
| Closed | -$186K | – | 3775 |
|
|
2016
Q1 | $186K | Buy |
11,124
+475
| +4% | +$7.94K | ﹤0.01% | 3499 |
|
|
2015
Q4 | $330K | Buy |
+10,649
| New | +$330K | ﹤0.01% | 3417 |
|